About 6% of pregnancy-related cancers are Hodgkin lymphoma, and 5% are non-Hodgkin lymphoma. Leukemias in pregnancy are rarer ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukaemia in people at high risk of the disease, a study ...

Researchers from The University of Osaka identify a molecule that can support specific therapeutic targeting of AML with ...

An analysis of 2 pharmacovigilance databases revealed a high prevalence of azacitidine-related adverse events in patients with MDS or AML.

The bone marrow environment evolves in ways that support the cancer, and I’m a firm believer that to treat cancer effectively ...

Allogene Therapeutics, Inc.’s ALLO share price has surged by 6.64%, which has investors questioning if this is right time to ...

The adult T-cell leukemia or lymphoma treatment market size has ... 2024 report/leukemia-therapeutics-global-market-report Acute Myeloid Leukemia Global Market Report 2024 report/acute-myeloid ...

Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML ... will determine the next steps in development around ...